Regulation of macrophage in adipose tissue by CXCL14 and its receptor.
Project/Area Number |
25860304
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Experimental pathology
|
Research Institution | Tokyo Metropolitan Institute of Medical Science |
Principal Investigator |
TANEGASHIMA Kosuke 公益財団法人東京都医学総合研究所, 生体分子先端研究分野, 主任研究員 (20507678)
|
Project Period (FY) |
2013-04-01 – 2016-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2015: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2014: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2013: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Keywords | CXCL14 / 炎症 / 炎症反応 / CXCL12 / CXCR4 |
Outline of Final Research Achievements |
Disruption of CXCL14 in mice ameliorates obesity-induced chronic inflammation. We aimed to investigate how CXCL14 activates inflammatory signaling at the molecular level. We found that CXCL14 specifically bound to a TLR9-ligand, CpG DNA and acted as a cofactor. CXCL14/CpG DNA complex was efficiently incorporated into dendritic cells and macrophages and induced robust expression of Th1 type inflammatory cytokines. These results suggested that CXCL14 plays a new role for the activation of the innate immune pathway.
|
Report
(4 results)
Research Products
(18 results)